PDT Partners’s Enzo Biochem, Inc. ENZ Stock Holding History

PDT Partners’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-41,800	Closed	-$213K	–	563
2016 Q3	$213K	Buy	41,800 +7,980	+24%	+$47.7K	0.01%	437
2016 Q2	$202K	Buy	33,820 +15,720	+87%	+$87.2K	0.02%	398
2016 Q1	$82K	Hold	18,100	–	–	0.01%	546
2015 Q4	$81K	Buy	+18,100	New	+$76.4K	0.01%	380
2015 Q1	–	Sell	-29,300	Closed	-$130K	–	1448
2014 Q4	$130K	Buy	29,300 +5,800	+25%	+$27.7K	0.01%	590
2014 Q3	$121K	Hold	23,500	–	–	﹤0.01%	1225
2014 Q2	$123K	Buy	+23,500	New	+$102K	﹤0.01%	1355

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

PDT Partners's ENZ Position: Q4 2016 in Review

PDT Partners sold out of Enzo Biochem, Inc. (ENZ) in Q4 2016, closing a stake of 41,800 shares — an estimated $213K sold.

PDT Partners first reported a position in ENZ in Q2 2014 and held it in 7 quarters. The position peaked at $213K in Q3 2016. 109 funds tracked by Wall St. Rank hold ENZ as of Q4 2016.

PDT Partners reported no remaining Enzo Biochem, Inc. position as of Q4 2016 after selling out during the quarter.
PDT Partners sold 41,800 Enzo Biochem, Inc. shares in Q4 2016, an estimated $213K.
PDT Partners first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 7 quarters.
PDT Partners's Enzo Biochem, Inc. position peaked at $213K in Q3 2016.
109 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q4 2016.

Based on PDT Partners's 13F filing for Q4 2016, filed 14 Feb 2017.